메뉴 건너뛰기




Volumn 21, Issue 1, 2003, Pages 49-57

Camptothecin analogues and vinblastine in the treatment of renal cell carcinoma: An in vivo study using a human orthotopic renal cancer xenograft

Author keywords

Animal model; Chemotherapy; Renal tumors

Indexed keywords

9 AMINOCAMPTOTHECIN; IRINOTECAN; VINBLASTINE; 9 AMINO 20 CAMPTOTHECIN; 9-AMINO-20-CAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

EID: 0141922733     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(02)00243-0     Document Type: Article
Times cited : (11)

References (29)
  • 1
    • 0027273479 scopus 로고
    • Cytotoxic chemotherapy for advanced renal cell carcinoma
    • Yagoda A, Petrylak D, Thompson S. Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin N Amer 1993;20:303-21.
    • (1993) Urol Clin N Amer , vol.20 , pp. 303-321
    • Yagoda, A.1    Petrylak, D.2    Thompson, S.3
  • 2
    • 0024205702 scopus 로고
    • The role of biological response modifiers in metastatic renal carcinoma
    • Muss HB. The role of biological response modifiers in metastatic renal carcinoma. Sem Surg Onc 1988;15(Suppl.5):30-4.
    • (1988) Sem Surg Onc , vol.15 , Issue.SUPPL. 5 , pp. 30-34
    • Muss, H.B.1
  • 3
    • 0023749717 scopus 로고
    • Biologic Response Modifiers in metastatic renal carcinoma
    • Quesada JR. Biologic Response Modifiers in metastatic renal carcinoma. Sem Onc 1988;15:396-407.
    • (1988) Sem Onc , vol.15 , pp. 396-407
    • Quesada, J.R.1
  • 4
    • 0023115642 scopus 로고
    • A progress report on the treatment of 157 patients with advanced cancer using lymphocyteactivated killer cells and interleukin-2 or high dose interleukin-2 alone
    • Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphocyteactivated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987;316:889-97.
    • (1987) N Engl J Med , vol.316 , pp. 889-897
    • Rosenberg, S.A.1    Lotze, M.T.2    Muul, L.M.3
  • 5
    • 7144248725 scopus 로고
    • Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
    • Wall ME, Wani MC, Cook CE, Palmer KH, MCPhail AT, Sim GA. Plant antitumor agents. 1. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 1966;88:3888-90.
    • (1966) J Am Chem Soc , vol.88 , pp. 3888-3890
    • Wall, M.E.1    Wani, M.C.2    Cook, C.E.3    Palmer, K.H.4    McPhail, A.T.5    Sim, G.A.6
  • 6
    • 0015150039 scopus 로고
    • Studies on camptothecin: 1. Effects on nucleic acid and protein synthesis
    • Horwitz SB, Chang CSCK, Grollman AP. Studies on camptothecin: 1. Effects on nucleic acid and protein synthesis. Mol. Pharmacol 1971;7:632-44.
    • (1971) Mol. Pharmacol , vol.7 , pp. 632-644
    • Horwitz, S.B.1    Chang, C.S.C.K.2    Grollman, A.P.3
  • 7
    • 0023924786 scopus 로고
    • Identification of mammalian DNA topoisomerase 1 as an intracellular target of the anticancer drug Camptothecin
    • Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase 1 as an intracellular target of the anticancer drug Camptothecin. Cancer Res 1988;48:1722-6.
    • (1988) Cancer Res , vol.48 , pp. 1722-1726
    • Hsiang, Y.H.1    Liu, L.F.2
  • 8
    • 0023552964 scopus 로고
    • Antitumor activity of 7-ethyl-10-[4-( 1-piperidino)-1-piperidino] carbonyloxycamptothecin, against murine tumors
    • Kunimoto T, Nitta K, Tanaka T, et al. Antitumor activity of 7-ethyl-10-[4-( 1-piperidino)-1-piperidino]carbonyloxycamptothecin, against murine tumors. Cancer Res 1987;47:5944-7.
    • (1987) Cancer Res , vol.47 , pp. 5944-5947
    • Kunimoto, T.1    Nitta, K.2    Tanaka, T.3
  • 9
    • 33644569988 scopus 로고
    • Camptothecin analogues and Cisplatin: An effective therapy of advanced human bladder cancer
    • Amsterdam: European Cancer Center
    • Keane TE, Petros JA, McGuire W, et al. Camptothecin analogues and Cisplatin: An effective therapy of advanced human bladder cancer. Abst#59 6th conference on DNA Topoisomerases in therapy. Amsterdam: European Cancer Center, 1995.
    • (1995) Abst#59 6th Conference on DNA Topoisomerases in Therapy
    • Keane, T.E.1    Petros, J.A.2    McGuire, W.3
  • 10
    • 0026531753 scopus 로고
    • A phase 11 study of CPT-11, a new derivative of camptothecin, for previously untreated non small cell lung cancer
    • Fukuoka M, Niitani H, Suzuki A, et al. A phase 11 study of CPT-11, a new derivative of camptothecin, for previously untreated non small cell lung cancer. J Clin Oncol 1992;10:16-20.
    • (1992) J Clin Oncol , vol.10 , pp. 16-20
    • Fukuoka, M.1    Niitani, H.2    Suzuki, A.3
  • 11
    • 0000107302 scopus 로고
    • Phase 11 study of CPT-11, a new camptothecin derivative, in small cell lung cancer
    • Negoro S, Fukuoka M, Niitani H, Taguchi T. Phase 11 study of CPT-11, a new camptothecin derivative, in small cell lung cancer. Proc Am Soc Clin Oncol 1991;10:241.
    • (1991) Proc Am Soc Clin Oncol , vol.10 , pp. 241
    • Negoro, S.1    Fukuoka, M.2    Niitani, H.3    Taguchi, T.4
  • 12
    • 0027813132 scopus 로고
    • In vitro and in vivo effects of clinically important camptothecin analogues on multidrug resistant cells
    • Marren MR, Hoffman GA, Polsky RM, Funk LR, McCabe FL, Johnson RK. In vitro and in vivo effects of clinically important camptothecin analogues on multidrug resistant cells. Oncol Res 1993; 5:467-74.
    • (1993) Oncol Res , vol.5 , pp. 467-474
    • Marren, M.R.1    Hoffman, G.A.2    Polsky, R.M.3    Funk, L.R.4    McCabe, F.L.5    Johnson, R.K.6
  • 13
    • 0025194067 scopus 로고
    • Dipyridamole-cisplatin potentiation: Enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers
    • Keane TE, Rosner G, Donaldson JT, Norwood DL, Poulton SH, Walther PJ. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. J Urol 1990;144:1004-9.
    • (1990) J Urol , vol.144 , pp. 1004-1009
    • Keane, T.E.1    Rosner, G.2    Donaldson, J.T.3    Norwood, D.L.4    Poulton, S.H.5    Walther, P.J.6
  • 16
    • 0028054890 scopus 로고
    • Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: Analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model
    • Keane TE, Gingrich JR, Rosner G, Webb KS, Poulton SH, Walther PJ. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model. Cancer Res 1994; 54:475-81.
    • (1994) Cancer Res , vol.54 , pp. 475-481
    • Keane, T.E.1    Gingrich, J.R.2    Rosner, G.3    Webb, K.S.4    Poulton, S.H.5    Walther, P.J.6
  • 19
    • 0024329881 scopus 로고
    • The biochemistry of P-glycoprotein mediated multi drug resistance
    • Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multi drug resistance. Annu Rev Biochem 1989;58:137-71.
    • (1989) Annu Rev Biochem , vol.58 , pp. 137-171
    • Endicott, J.A.1    Ling, V.2
  • 20
    • 0024779132 scopus 로고
    • P-glycoprotein multidrug resistance and a superfamily of membrane associated transport proteins
    • Juranka PF, Zastawny RL, Ling V. P-glycoprotein multidrug resistance and a superfamily of membrane associated transport proteins. FASEB J 1989;3:2583-92.
    • (1989) FASEB J , vol.3 , pp. 2583-2592
    • Juranka, P.F.1    Zastawny, R.L.2    Ling, V.3
  • 21
    • 0022496762 scopus 로고
    • Misonidazole induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl- 1-nitrosurea toxicity in 06 methylguanine-DNA methyltransferase proficient (mer+) and deficient (mer-) cell lines
    • Mulcahy RT. Misonidazole induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosurea toxicity in 06 methylguanine-DNA methyltransferase proficient (mer+) and deficient (mer-) cell lines. Cancer Res 1986;46:2892-7.
    • (1986) Cancer Res , vol.46 , pp. 2892-2897
    • Mulcahy, R.T.1
  • 22
    • 0029960812 scopus 로고    scopus 로고
    • Eukaryotic DNA Topoisomerase 1: Genome Gatekeeper and its intruders, Camptothecins
    • Pommier Y. Eukaryotic DNA Topoisomerase 1: Genome Gatekeeper and its intruders, Camptothecins. Seminars in Oncology 1996; 23(suppl 3):3-10.
    • (1996) Seminars in Oncology , vol.23 , Issue.SUPPL. 3 , pp. 3-10
    • Pommier, Y.1
  • 24
    • 0027324850 scopus 로고
    • Therapeutic efficacy of the topoisomerase 1 inhibitor 7-ethyl-10(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: Lack of cross resistance in vivo in tumors with acquired resistance to the topoisomerase 1 inhibitor 9-dimethylaminomethyl-10- hydroxycamptothecin
    • Houghton PJ, Cheshire PJ, Hallman JC, Bissery MC, Mathieu-Boue A, Houghton JD. Therapeutic efficacy of the topoisomerase 1 inhibitor 7-ethyl-10(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross resistance in vivo in tumors with acquired resistance to the topoisomerase 1 inhibitor 9-dimethylaminomethyl-10- hydroxycamptothecin. Ca Res 1993;53: 2823-9.
    • (1993) Ca Res , vol.53 , pp. 2823-2829
    • Houghton, P.J.1    Cheshire, P.J.2    Hallman, J.C.3    Bissery, M.C.4    Mathieu-Boue, A.5    Houghton, J.D.6
  • 25
    • 0027471350 scopus 로고
    • Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between nontumorigenic and tumorigenic cells in vitro
    • Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between nontumorigenic and tumorigenic cells in vitro. Int J Cancer 1993;53: 863-71.
    • (1993) Int J Cancer , vol.53 , pp. 863-871
    • Pantazis, P.1    Kozielski, A.J.2    Mendoza, J.T.3    Early, J.A.4    Hinz, H.R.5    Giovanella, B.C.6
  • 26
    • 0022340594 scopus 로고
    • Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase1
    • Hsiang YH, Hertzberg R, Hecht S, Lui L. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase1. J Biol Chem 1985;260:14873-8.
    • (1985) J Biol Chem , vol.260 , pp. 14873-14878
    • Hsiang, Y.H.1    Hertzberg, R.2    Hecht, S.3    Lui, L.4
  • 27
    • 0031755364 scopus 로고    scopus 로고
    • Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression
    • Singh A, Tong A, Ognoskie N, Meyer W, Nemunaitis J. Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression. Am J Clin Oncol 1998;21(5):466-9.
    • (1998) Am J Clin Oncol , vol.21 , Issue.5 , pp. 466-469
    • Singh, A.1    Tong, A.2    Ognoskie, N.3    Meyer, W.4    Nemunaitis, J.5
  • 28
    • 0035890465 scopus 로고    scopus 로고
    • Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients
    • Becouarn Y, Gamelin E, Coudert B, et al. Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 2001;19:4195-201.
    • (2001) J Clin Oncol , vol.19 , pp. 4195-4201
    • Becouarn, Y.1    Gamelin, E.2    Coudert, B.3
  • 29
    • 0035873927 scopus 로고    scopus 로고
    • Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
    • Kemeny N, Gonen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001;19:2687-95.
    • (2001) J Clin Oncol , vol.19 , pp. 2687-2695
    • Kemeny, N.1    Gonen, M.2    Sullivan, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.